Comirnaty KP.2 30 micrograms/dose dispersion for injection, Adults and adolescents from 12 years
*Company:
Pfizer Healthcare Ireland Unlimited CompanyStatus:
No Recent UpdateLegal Category:
Product subject to medical prescription which may not be renewed (A)Active Ingredient(s):
This medicinal product is subject to additional monitoring.
*Additional information is available within the SPC or upon request to the company
Updated on 21 October 2024
File name
Adv SPC COMIRNATY KP.2 30 mcg bCY 2_0 IE & NI.pdf
Reasons for updating
- Change to section 3 - Pharmaceutical form
- Change to section 4.2 - Posology and method of administration
- Change to section 4.8 - Undesirable effects
- Change to section 4.9 - Overdose
- Change to section 5.1 - Pharmacodynamic properties
Legal category:Product subject to medical prescription which may not be renewed (A)
Updated on 17 October 2024
File name
Adv SPC COMIRNATY KP.2 30 mcg bCY 2_0 IE & NI.pdf
Reasons for updating
- Change to section 3 - Pharmaceutical form
- Change to section 4.2 - Posology and method of administration
- Change to section 4.8 - Undesirable effects
- Change to section 4.9 - Overdose
- Change to section 5.1 - Pharmacodynamic properties
Legal category:Product subject to medical prescription which may not be renewed (A)
Updated on 01 October 2024
File name
Adv SPC COMIRNATY KP.2 30 mcg bCY 1_0 IE & NI.pdf
Reasons for updating
- New SPC for new product
Legal category:Product subject to medical prescription which may not be renewed (A)
Free text change information supplied by the pharmaceutical company
New SPCs to reflect the new Pfizer/BNT Marketing Authorisation
Updated on 01 October 2024
File name
Adv PIL COMIRNATY KP.2 30 mcg MDV & SDV bCY 1_0 IE & NI.pdf
Reasons for updating
- New PIL for new product
Free text change information supplied by the pharmaceutical company
New PILs to reflect the new Pfizer/BNT Marketing Authorisation